Syros Pharmaceuticals, Inc. · OTC:SYRS
Avidity Partners Management LP's stake in Syros Pharmaceuticals, Inc. fell to 7.60% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Avidity Partners Management LP's stake in Syros Pharmaceuticals, Inc. fell to 7.60%, 2,048,020 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 7.60%
- Shares
- 2,048,020
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avidity Partners Management LP | 7.60% | 2,048,020 |
| Avidity Partners Management (GP) LLC | 7.60% | 2,048,020 |
| Avidity Capital Partners Fund (GP) LP | 7.60% | 2,048,020 |
| Avidity Capital Partners (GP) LLC | 7.60% | 2,048,020 |
| Avidity Master Fund LP | 2.90% | 781,970 |
| Avidity Private Master Fund I LP | 4.40% | 1,169,610 |
| David Witzke | 0% | 0 |
| Michael Gregory | 7.60% | 2,048,020 |